RT1-A Activators

RT1-A Activators primarily function by activating or regulating immune response pathways that lead to the upregulation of MHC class I molecules like RT1-A. These compounds generally work by triggering pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), leading to the activation of transcription factors such as NF-κB and IRF1, which in turn enhance the expression of MHC class I molecules.

The specific mode of action varies for each compound. For instance, Poly I:C and LPS act as agonists for TLR3 and TLR4 respectively, stimulating pathways that lead to NF-κB activation and subsequently enhanced MHC class I expression. Other compounds like Imiquimod and Resiquimod target TLR7. Regardless of their specific targets, the overall effect of these compounds is to enhance RT1-A expression and function.